| Date Filed | Type | Description |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 09/27/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 10,000 shares
@ $4.163, valued at
$41.6k
|
|
| 11/23/2020 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Bought 10,000 shares
@ $8.03, valued at
$80.3k
|
|
| 09/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 3,056 shares
@ $4.6599, valued at
$14.2k
|
|
| 09/21/2020 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Bought 10,000 shares
@ $4.766, valued at
$47.7k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2019 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 7,650 options to buy
@ $0 |
|
| 03/05/2018 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 8,000 options to buy
@ $0.72, valued at
$5.8k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2017 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on Nivalis Therapeutics, Inc. |
| 05/10/2017 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on Nivalis Therapeutics, Inc. |
| 05/09/2017 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on Nivalis Therapeutics, Inc. |
| 05/08/2017 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on Nivalis Therapeutics, Inc. |
| 03/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/14/2016 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on Nivalis Therapeutics, Inc. |
| 02/16/2016 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 8,000 options to buy
@ $3.44, valued at
$27.5k
|
|
| 12/11/2015 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on Nivalis Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $8.1, valued at
$81k
|
|
| 09/15/2015 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on Nivalis Therapeutics, Inc.|
Txns:
| Granted 7,650 options to buy
@ $0 |
|
| 07/20/2015 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on Nivalis Therapeutics, Inc.|
Txns:
| Granted 11,475 options to buy
@ $0 |
|
| 02/17/2015 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 8,000 options to buy
@ $0.67, valued at
$5.4k
|
|
| 02/13/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/19/2013 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Granted 14,750 options to buy
@ $1.38, valued at
$20.4k
Granted 2,608 options to buy
@ $1.38, valued at
$3.6k
|
|
|